Construct: ORF ccsbBroadEn_14940

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF018922.1_s300c1, BRDN0000458218
DNA Barcode:
None
Epitope Tag:
None
Notes:
Early stop codon detected

Originally Annotated References:

Gene:
MAP4K4 (9448)

Vector Information:

Vector Backbone:
pDONR223
Pol II Cassette 1:
n/a
Pol II Cassette 2:
n/a
Selection Marker:
n/a
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 9448 MAP4K4 mitogen-activated protein k... XM_017005372.1 99.9% 19.6% 685delG
2 human 9448 MAP4K4 mitogen-activated protein k... NM_004834.5 99.8% 19.7% 685delG;1715_1716insCAG
3 human 9448 MAP4K4 mitogen-activated protein k... XM_017005373.1 99.7% 19.7% 685delG;1968_1969insGGCGAAGTG
4 human 9448 MAP4K4 mitogen-activated protein k... XM_017005374.1 99.2% 19.8% 685delG;3093_3094ins24
5 human 9448 MAP4K4 mitogen-activated protein k... XM_017005375.1 99% 19.8% 685delG;1968_1969insGGCGAAGTG;3084_3085ins24
6 human 9448 MAP4K4 mitogen-activated protein k... XM_017005369.1 97.2% 19.1% 685delG;1482_1574del;1808_1809insCAG
7 human 9448 MAP4K4 mitogen-activated protein k... XM_006712869.2 96.7% 19.3% 685delG;1482_1574del;3186_3187ins24
8 human 9448 MAP4K4 mitogen-activated protein k... XM_017005370.1 96.6% 19.3% (many diffs)
9 human 9448 MAP4K4 mitogen-activated protein k... XM_017005371.1 96.4% 19.3% (many diffs)
10 human 9448 MAP4K4 mitogen-activated protein k... XM_005264071.2 96.3% 19.3% (many diffs)
11 human 9448 MAP4K4 mitogen-activated protein k... NM_145687.4 94.8% 18.9% 685delG;1610_1771del;3255_3256ins24
12 human 9448 MAP4K4 mitogen-activated protein k... XM_017005368.1 94.8% 18.9% (many diffs)
13 human 9448 MAP4K4 mitogen-activated protein k... XM_005264065.3 94.7% 18.6% 685delG;2273_2464del
14 human 9448 MAP4K4 mitogen-activated protein k... XM_005264066.3 94.6% 18.6% 685delG;1715_1716insCAG;2270_2461del
15 human 9448 MAP4K4 mitogen-activated protein k... XM_005264069.2 94.6% 18.9% (many diffs)
16 human 9448 MAP4K4 mitogen-activated protein k... XM_005264068.3 94.5% 18.7% 685delG;1968_1969insGGCGAAGTG;2264_2455del
17 human 9448 MAP4K4 mitogen-activated protein k... XM_006712868.2 94.1% 18.7% 685delG;2273_2464del;3285_3286ins24
18 human 9448 MAP4K4 mitogen-activated protein k... XM_017005366.1 93.7% 18.4% 685delG;1611_1841del
19 human 9448 MAP4K4 mitogen-activated protein k... NM_001242560.2 93.1% 18.5% 685delG;1611_1841del;3324_3325ins24
20 human 9448 MAP4K4 mitogen-activated protein k... XM_017005367.1 93% 18.6% (many diffs)
21 human 9448 MAP4K4 mitogen-activated protein k... XM_017005365.1 92.5% 18.4% (many diffs)
22 human 9448 MAP4K4 mitogen-activated protein k... XM_005264062.3 92.4% 18.2% 685delG;1482_1574del;2366_2557del
23 human 9448 MAP4K4 mitogen-activated protein k... XM_005264063.3 92.3% 18.2% (many diffs)
24 human 9448 MAP4K4 mitogen-activated protein k... NM_001242559.2 92.2% 18.5% (many diffs)
25 human 9448 MAP4K4 mitogen-activated protein k... XM_005264064.3 92.2% 18.2% (many diffs)
26 human 9448 MAP4K4 mitogen-activated protein k... XM_017005363.1 91.8% 18.3% (many diffs)
27 human 9448 MAP4K4 mitogen-activated protein k... XM_017005359.1 91.4% 18% 685delG;1482_1574del;1704_1934del
28 human 9448 MAP4K4 mitogen-activated protein k... XM_017005364.1 91.4% 18.3% (many diffs)
29 human 9448 MAP4K4 mitogen-activated protein k... XM_017005360.1 91.4% 18% (many diffs)
30 human 9448 MAP4K4 mitogen-activated protein k... XM_017005361.1 90.8% 18.1% (many diffs)
31 human 9448 MAP4K4 mitogen-activated protein k... XM_017005362.1 90.7% 18.1% (many diffs)
32 human 9448 MAP4K4 mitogen-activated protein k... XM_005264059.3 90.7% 17.8% 685delG;1610_1771del;2435_2626del
33 human 9448 MAP4K4 mitogen-activated protein k... XM_017005356.1 90.5% 17.9% (many diffs)
34 human 9448 MAP4K4 mitogen-activated protein k... XM_005264060.3 90.4% 17.9% (many diffs)
35 human 9448 MAP4K4 mitogen-activated protein k... XM_017005357.1 90.1% 17.9% (many diffs)
36 human 9448 MAP4K4 mitogen-activated protein k... XM_017005358.1 90% 18% (many diffs)
37 human 9448 MAP4K4 mitogen-activated protein k... NM_145686.3 89.9% 18% (many diffs)
38 human 9448 MAP4K4 mitogen-activated protein k... XM_006712865.2 89.1% 17.5% 685delG;1611_1841del;2504_2695del
39 human 9448 MAP4K4 mitogen-activated protein k... XM_005264057.3 88.6% 17.4% (many diffs)
40 human 9448 MAP4K4 mitogen-activated protein k... XM_017005354.1 88.5% 17.6% (many diffs)
41 human 9448 MAP4K4 mitogen-activated protein k... XM_005264058.3 88.4% 17.5% (many diffs)
42 human 9448 MAP4K4 mitogen-activated protein k... XM_017005355.1 88.3% 17.7% (many diffs)
43 human 9448 MAP4K4 mitogen-activated protein k... XM_017005351.1 88.3% 17.5% (many diffs)
44 human 9448 MAP4K4 mitogen-activated protein k... XM_017005352.1 88% 17.5% (many diffs)
45 human 9448 MAP4K4 mitogen-activated protein k... XM_017005353.1 87.9% 17.5% (many diffs)
46 human 9448 MAP4K4 mitogen-activated protein k... XM_005264050.3 87.1% 17.1% (many diffs)
47 human 9448 MAP4K4 mitogen-activated protein k... XM_005264052.3 87% 17.1% (many diffs)
48 human 9448 MAP4K4 mitogen-activated protein k... XM_017005350.1 86.5% 17.2% (many diffs)
49 human 9448 MAP4K4 mitogen-activated protein k... XM_017005349.1 84.9% 16.9% (many diffs)
50 human 9448 MAP4K4 mitogen-activated protein k... XM_005264048.2 83.1% 16.5% (many diffs)
51 mouse 26921 Map4k4 mitogen-activated protein k... XM_006496046.1 89.2% 19.8% (many diffs)
52 mouse 26921 Map4k4 mitogen-activated protein k... XM_006496045.1 85.4% 18.9% (many diffs)
53 mouse 26921 Map4k4 mitogen-activated protein k... NM_001252202.1 85.2% 19% (many diffs)
54 mouse 26921 Map4k4 mitogen-activated protein k... NM_001252201.1 84.7% 18.8% (many diffs)
55 mouse 26921 Map4k4 mitogen-activated protein k... NM_008696.2 83.8% 18.6% (many diffs)
56 mouse 26921 Map4k4 mitogen-activated protein k... XM_006496044.1 83% 18.5% (many diffs)
57 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321018.1 82.6% 18.3% (many diffs)
58 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321021.1 82.4% 18.3% (many diffs)
59 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321016.1 81.1% 18% (many diffs)
60 mouse 26921 Map4k4 mitogen-activated protein k... XM_006496043.1 80.9% 18% (many diffs)
61 mouse 26921 Map4k4 mitogen-activated protein k... NM_001252200.1 80.3% 17.8% (many diffs)
62 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321013.1 79.7% 17.6% (many diffs)
63 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321011.1 79.2% 17.5% (many diffs)
64 mouse 26921 Map4k4 mitogen-activated protein k... XM_011238530.1 78.4% 17.4% (many diffs)
65 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321010.1 78.2% 17.4% (many diffs)
66 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321004.1 77.9% 17.3% (many diffs)
67 mouse 26921 Map4k4 mitogen-activated protein k... XM_006496042.1 77.8% 17.2% (many diffs)
68 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321002.1 76.5% 16.9% (many diffs)
69 mouse 26921 Map4k4 mitogen-activated protein k... XM_017320998.1 74.9% 16.6% (many diffs)
70 mouse 26921 Map4k4 mitogen-activated protein k... XM_006496041.1 74.8% 16.6% (many diffs)
71 mouse 26921 Map4k4 mitogen-activated protein k... XM_017320994.1 74.7% 16.6% (many diffs)
72 mouse 26921 Map4k4 mitogen-activated protein k... XM_017321001.1 74.6% 16.6% (many diffs)
73 mouse 26921 Map4k4 mitogen-activated protein k... XR_001784730.1 57.4% (many diffs)
74 mouse 26921 Map4k4 mitogen-activated protein k... XR_001784729.1 51.7% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
92
ORF end:
806
ORF length:
714
Sequence:
1ATTATTTTGA CTGATAGTGA CCTGTTCGTT GCAACAAATT GATGAGCAAT GCTTTTTTAT
61AATGCCAACT TTGTACAAAA AAGTTGGCAC CATGGCGAAC GACTCCCCTG CAAAAAGTCT
121GGTGGACATC GACCTCTCCT CCCTGCGGGA TCCTGCTGGG ATTTTTGAGC TGGTGGAAGT
181GGTTGGAAAT GGCACCTATG GACAAGTCTA TAAGGGTCGA CATGTTAAAA CGGGTCAGTT
241GGCAGCCATC AAAGTTATGG ATGTCACTGA GGATGAAGAG GAAGAAATCA AACTGGAGAT
301AAATATGCTA AAGAAATACT CTCATCACAG AAACATTGCA ACATATTATG GTGCTTTCAT
361CAAAAAGAGC CCTCCAGGAC ATGATGACCA ACTCTGGCTT GTTATGGAGT TCTGTGGGGC
421TGGGTCCATT ACAGACCTTG TGAAGAACAC CAAAGGGAAC ACACTCAAAG AAGACTGGAT
481CGCTTACATC TCCAGAGAAA TCCTGAGGGG ACTGGCACAT CTTCACATTC ATCATGTGAT
541TCACCGGGAT ATCAAGGGCC AGAATGTGTT GCTGACTGAG AATGCAGAGG TGAAACTTGT
601TGACTTTGGT GTGAGTGCTC AGCTGGACAG GACTGTGGGG CGGAGAAATA CGTTCATAGG
661CACTCCCTAC TGGATGGCTC CTGAGGTCAT CGCCTGTGAT GAGAACCCAG ATGCCACCTA
721TGATTACAGA AGTGATCTTT GGTCTTGTGG CATTACAGCC ATTGAGATGG CAGAAGTGCT
781CCCCCTCTCT GTGACATGCA TCCAATGAGA GCACTGTTTC TCATTCCCAG AAACCCTCCT
841CCCCGGCTGA AGTCAAAAAA ATGGTCGAAG AAGTttttta gttttataga agggtgcctg
901gtgaagaatt acatgcagcg gccctctaca gagcagcttt tgaaacatcc ttttataagg
961gatcagccaa atgaaaggca agttagaatc cagcttaagg atcatataga tcgtaccagg
1021aagaagagag gcgagaaaga tgaaactgag tatgagtaca gtgggagtga ggaagaagag
1081gaggaagtgc ctgaacagga aggagagcca agttccattg tgaacgtgcc tggtgagtct
1141actcttcgcc gagatttcct gagactgcag caggagaaca aggaacgttc cgaggctctt
1201cggagacaac agttactaca ggagcaacag ctccgggagc aggaagaata taaaaggcaa
1261ctgctggcag agagacagaa gcggattgag cagcagaaag aacagaggcg acggctagaa
1321gagcaacaaa ggagagagcg ggaagctaga aggcagcagg aacgtgaaca gcgaaggaga
1381gaacaagaag aaaagaggcg tctagaggag ttggagagaa ggcgcaaaga agaagaggag
1441aggagacggg cagaagaaga aaagaggaga gttgaaagag aacaggagta tatcaggcga
1501cagctagaag aggagcagcg gcacttggaa gtccttcagc agcagctgct ccaggagcag
1561gccatgttac tgcatgacca taggaggccg cacccgcagc actcgcagca gccgccacca
1621ccgcagcagg aaaggagcaa gccaagcttc catgctcccg agcccaaagc ccactacgag
1681cctgctgacc gagcgcgaga ggttcctgtg agaacaacat ctcgctcccc tgttctgtcc
1741cgtcgagatt ccccactgca gggcagtggg cagcagaata gccaggcagg acagagaaac
1801tccaccagca gtattgagcc caggcttctg tgggagagag tggagaagct ggtgcccaga
1861cctggcagtg gcagctcctc agggtccagc aactcaggat cccagcccgg gtctcaccct
1921gggtctcaga gtggctccgg ggaacgcttc agagtgagat catcatccaa gtctgaaggc
1981tctccatctc agcgcctgga aaatgcagtg aaaaaacctg aagataaaaa ggaagttttc
2041agacccctca agcctgctgg cgaagtggat ctgaccgcac tggccaaaga gcttcgagca
2101gtggaagatg tacggccacc tcacaaagta acggactact cctcatccag tgaggagtcg
2161gggacgacgg atgaggagga cgacgatgtg gagcaggaag gggctgacga gtccacctca
2221ggaccagagg acaccagagc agcgtcatct ctgaatttga gcaatggtga aacggaatct
2281gtgaaaacca tgattgtcca tgatgatgta gaaagtgagc cggccatgac cccatccaag
2341gagggcactc taatcgtccg ccagactcag tccgctagta gcacactcca gaaacacaaa
2401tcttcctcct cctttacacc ttttatagac cccagattac tacagatttc tccatctagc
2461ggaacaacag tgacatctgt ggtgggattt tcctgtgatg ggatgagacc agaagccata
2521aggcaagatc ctacccggaa aggctcagtg gtcaatgtga atcctaccaa cactaggcca
2581cagagtgaca ccccggagat tcgtaaatac aagaagaggt ttaactctga gattctgtgt
2641gctgccttat ggggagtgaa tttgctagtg ggtacagaga gtggcctgat gctgctggac
2701agaagtggcc aagggaaggt ctatcctctt atcaaccgaa gacgatttca acaaatggac
2761gtacttgagg gcttgaatgt cttggtgaca atatctggca aaaaggataa gttacgtgtc
2821tactatttgt cctggttaag aaataaaata cttcacaatg atccagaagt tgagaagaag
2881cagggatgga caaccgtagg ggatttggaa ggatgtgtac attataaagt tgtaaaatat
2941gaaagaatca aatttctggt gattgctttg aagagttctg tggaagtcta tgcgtgggca
3001ccaaagccat atcacaaatt tatggccttt aagtcatttg gagaattggt acataagcca
3061ttactggtgg atctcactgt tgaggaaggc cagaggttga aagtgatcta tggatcctgt
3121gctggattcc atgctgttga tgtggattca ggatcagtct atgacattta tctaccaaca
3181catgtaagaa agaacccaca ctctatgatc cagtgtagca tcaaacccca tgcaatcatc
3241atcctcccca atacagatgg aatggagctt ctggtgtgct atgaagatga gggggtttat
3301gtaaacacat atggaaggat caccaaggat gtagttctac agtggggaga gatgcctaca
3361tcagtagcat atattcgatc caatcagaca atgggctggg gagagaaggc catagagatc
3421cgatctgtgg aaactggtca cttggatggt gtgttcatgc acaaaagggc tcaaagacta
3481aaattcttgt gtgaacgcaa tgacaaggtg ttctttgcct ctgttcggtc tggtggcagc
3541agtcaggttt atttcatgac cttaggcagg acttctcttc tgagctggtt gccaactttc
3601ttgtacaaag ttggcattat aagaaagcat tgcttatcaa tttgttgcaa cgaac

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.